We reported the presence of excessive S100B in the cerebrospinal fluid (CSF) and serum of MS patients at diagnosis, as well as in active lesions of post-mortem brain samples (Barateiro et al., 2016). The gene discussed is S100B; the disease is myeloid sarcoma.